Select Medical (SEM) investor relations material

Opening remarks and agenda

• Meeting called to order at 11:00 A.M. Eastern Time as a virtual audio webcast to facilitate stockholder participation and voting.

• Proxy statement and meeting notice were mailed to stockholders beginning May 22, 2026, with May 11, 2026, as the record date.

• Quorum established with more than half of outstanding shares present or represented by proxy.

Shareholder proposals

• Three proposals presented: approval of a merger agreement, a non-binding advisory vote on executive compensation related to the merger, and a potential adjournment proposal.

• Merger proposal involves the company becoming a wholly-owned subsidiary of Stallion Intermediate Corporation.

• Compensation proposal concerns arrangements for named executive officers in connection with the merger.

• Adjournment proposal was not put to a vote as the Board deemed it unnecessary.

Overview of voting outcomes

• Merger proposal approved by both a majority of all shares and a majority of unaffiliated stockholder shares voting.

• Compensation proposal approved by a majority of shares present or represented by proxy.

• Official vote count to be reported on Form 8-K within four business days.